BioXcel Therapeutics Earnings Date, Estimates & History

-0.67 (-2.70 %)
(As of 07/26/2021 01:32 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume17,057 shs
Average Volume482,296 shs
Market Capitalization$595.85 million
P/E RatioN/A
Dividend YieldN/A

BioXcel Therapeutics (NASDAQ:BTAI) Earnings Information

BioXcel Therapeutics last issued its earnings results on May 9th, 2021. The reported ($1.08) EPS for the quarter, missing the consensus estimate of ($0.89) by $0.19. BioXcel Therapeutics has generated ($3.79) earnings per share over the last year. BioXcel Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 13th, 2021 based off prior year's report dates.

BioXcel Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BioXcel Therapeutics (NASDAQ:BTAI) Earnings Estimates

2021 EPS Consensus Estimate: ($4.03)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211($0.80)($0.80)($0.80)
Q2 20213($1.06)($0.87)($0.96)
Q3 20213($1.25)($0.91)($1.05)
Q4 20213($1.67)($0.91)($1.22)

BioXcel Therapeutics (NASDAQ BTAI) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
8/6/2019Q2 2019($0.52)($0.54)($0.02)($0.54)
8/8/2018Q2 2018($0.32)($0.19)+$0.13($0.19)
5/14/2018Q1 2018($0.2570)($0.37)($0.1130)($0.37)
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/26/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.